|
|
|
Strategies and Best Practices for Outsourcing Clinical Research Services: Interactive Panel Discussion
by
Fred LeMoine, Michael Minor,
Cassandra
Kelley and Kevin Kelly
Moderated by Mary Kachinsky
The global Clinical Research Organization
(CRO) industry is growing at an annual rate of 15% as a result of increased
outsourcing by biopharmaceutical companies driven by larger more complex studies
on a global scale, more stringent regulatory requirements, and pressures to
reduce the cost of new treatments. With more than 1000 CROs in the marketplace,
how do you plan strategically and maximize the potential of your CRO
partnership? Panelists will discuss strategies and best practices related to
outsourcing clinical research services. Participants in this session will given
a chance to answer questions that will stimulate and steer the discussion.
Panelists will share their experiences and discuss the pros and cons of
different outsourcing models from both the CRO and Biopharma perspective.
• Understanding industry trends in strategic sourcing of clinical research
services and expectations over the next 5 to 10 years.
• Which outsourcing model is best for your organization?
• How can you maximize strategic relationships? Benefits to sponsor and
provider?
• What are the unique requirements to be considered for small pharma and biotech
companies?
• Procurements role in the outsourcing of clinical research services: How can
this be enhanced?
|
|